These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 15618539

  • 1. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
    Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE.
    Circ Res; 2005 Feb 04; 96(2):225-33. PubMed ID: 15618539
    [Abstract] [Full Text] [Related]

  • 2. Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy.
    Flagg TP, Cazorla O, Remedi MS, Haim TE, Tones MA, Bahinski A, Numann RE, Kovacs A, Schaffer JE, Nichols CG, Nerbonne JM.
    Circ Res; 2009 Jan 02; 104(1):95-103. PubMed ID: 19023131
    [Abstract] [Full Text] [Related]

  • 3. Genetic modification of the heart: transgenic modification of cardiac lipid and carbohydrate utilization.
    Hartil K, Charron MJ.
    J Mol Cell Cardiol; 2005 Oct 02; 39(4):581-93. PubMed ID: 16140322
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy.
    Vikramadithyan RK, Hirata K, Yagyu H, Hu Y, Augustus A, Homma S, Goldberg IJ.
    J Pharmacol Exp Ther; 2005 May 02; 313(2):586-93. PubMed ID: 15671204
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diabetes-related metabolic perturbations in cardiac myocyte.
    Feuvray D, Darmellah A.
    Diabetes Metab; 2008 Feb 02; 34 Suppl 1():S3-9. PubMed ID: 18358420
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy.
    Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J.
    J Mol Cell Cardiol; 2008 May 02; 44(5):927-37. PubMed ID: 18407290
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
    Pellieux C, Aasum E, Larsen TS, Montessuit C, Papageorgiou I, Pedrazzini T, Lerch R.
    J Mol Cell Cardiol; 2006 Sep 02; 41(3):459-66. PubMed ID: 16859699
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fatty acid transporters in plasma membranes of cardiomyocytes in patients with dilated cardiomyopathy.
    Pohl J, Fitscher BA, Ring A, Ihl-Vahl R, Strasser RH, Stremmel W.
    Eur J Med Res; 2000 Oct 30; 5(10):438-42. PubMed ID: 11076785
    [Abstract] [Full Text] [Related]

  • 17. Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling.
    Stilli D, Lagrasta C, Berni R, Bocchi L, Savi M, Delucchi F, Graiani G, Monica M, Maestri R, Baruffi S, Rossi S, Macchi E, Musso E, Quaini F.
    Basic Res Cardiol; 2007 Nov 30; 102(6):488-99. PubMed ID: 17585379
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation.
    Wang J, Song Y, Elsherif L, Song Z, Zhou G, Prabhu SD, Saari JT, Cai L.
    Circulation; 2006 Jan 31; 113(4):544-54. PubMed ID: 16432057
    [Abstract] [Full Text] [Related]

  • 20. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R, Oudit GY, Wang X, Zhang L, Ussher JR, Lopaschuk GD, Kassiri Z.
    Am J Physiol Heart Circ Physiol; 2009 Dec 31; 297(6):H2096-108. PubMed ID: 19801494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.